Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A block of the sphenopalatine ganglion in chronic rhinosinusitis with nasal polyposis
2015-004377-33Phase 2Completed
- Sponsor
- Department of Neuromedicine and Movement Science, NTNU
- Start
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of botulinum toxin type A in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Department of Neuromedicine and Movement Science, NTNU. Primary endpoint: Adverse events related to Botox and the surgical procedure. Started Dec 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on 2015-004377-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004377-33.